Tags

Type your tag names separated by a space and hit enter

Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.
J Subst Abuse Treat. 2007 Mar; 32(2):113-9.JS

Abstract

We determined the proportion of psychiatric treatments for disorders not due to substance use among a cohort of subjects (n = 3,114) seeking treatment for cannabis dependence. Data were retrieved from Danish treatment registers. Cases were compared with a representative sample, which was randomly selected from the general population according to age and gender (n = 15,570). Cannabis users were followed, and reentry into substance abuse treatment was used as an outcome deploying Cox regression analysis. The proportion of treatment for all psychiatric disorders was much higher among cases than among controls: schizophrenia (odds ratio [OR] = 7.9; 95% confidence interval [95% CI] = 6.1-10.2), bipolar disorders (OR = 4.9; 95% CI = 2.8-8.5), other affective disorders (OR = 7.6; 95% CI = 6.1-9.5), and personality disorders (OR = 17.3; 95% CI = 14.5-20.5). All in all, 40.7% of cases, compared with 5.2% of controls, had received psychiatric treatment (OR = 12.5; 95% CI = 11.3-13.8). A history of psychiatric treatment was associated with increased rates of reentry into substance abuse treatment, in general (OR = 1.35; 95% CI = 1.20-1.53), specifically for cannabis (OR = 1.26; 95% CI = 1.07-1.48) and opioid (OR = 1.56; 95% CI = 1.23-1.99) dependence. This is the first study to show that the proportion of psychiatric treatment is much elevated among subjects seeking treatment for cannabis dependence, and that a history of psychiatric problems is associated with higher rates of reentry into substance abuse treatment.

Authors+Show Affiliations

Center for Basic Psychiatric Research, Aarhus University Hospital, DK-8240 Risskov, Denmark. mca@psykiatri.aaa.dkNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17306720

Citation

Arendt, Mikkel, et al. "Psychopathology Among Cannabis-dependent Treatment Seekers and Association With Later Substance Abuse Treatment." Journal of Substance Abuse Treatment, vol. 32, no. 2, 2007, pp. 113-9.
Arendt M, Rosenberg R, Foldager L, et al. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment. J Subst Abuse Treat. 2007;32(2):113-9.
Arendt, M., Rosenberg, R., Foldager, L., Perto, G., & Munk-Jørgensen, P. (2007). Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment. Journal of Substance Abuse Treatment, 32(2), 113-9.
Arendt M, et al. Psychopathology Among Cannabis-dependent Treatment Seekers and Association With Later Substance Abuse Treatment. J Subst Abuse Treat. 2007;32(2):113-9. PubMed PMID: 17306720.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment. AU - Arendt,Mikkel, AU - Rosenberg,Raben, AU - Foldager,Leslie, AU - Perto,Gurli, AU - Munk-Jørgensen,Povl, Y1 - 2006/10/27/ PY - 2006/05/02/received PY - 2006/07/04/accepted PY - 2007/2/20/pubmed PY - 2007/5/3/medline PY - 2007/2/20/entrez SP - 113 EP - 9 JF - Journal of substance abuse treatment JO - J Subst Abuse Treat VL - 32 IS - 2 N2 - We determined the proportion of psychiatric treatments for disorders not due to substance use among a cohort of subjects (n = 3,114) seeking treatment for cannabis dependence. Data were retrieved from Danish treatment registers. Cases were compared with a representative sample, which was randomly selected from the general population according to age and gender (n = 15,570). Cannabis users were followed, and reentry into substance abuse treatment was used as an outcome deploying Cox regression analysis. The proportion of treatment for all psychiatric disorders was much higher among cases than among controls: schizophrenia (odds ratio [OR] = 7.9; 95% confidence interval [95% CI] = 6.1-10.2), bipolar disorders (OR = 4.9; 95% CI = 2.8-8.5), other affective disorders (OR = 7.6; 95% CI = 6.1-9.5), and personality disorders (OR = 17.3; 95% CI = 14.5-20.5). All in all, 40.7% of cases, compared with 5.2% of controls, had received psychiatric treatment (OR = 12.5; 95% CI = 11.3-13.8). A history of psychiatric treatment was associated with increased rates of reentry into substance abuse treatment, in general (OR = 1.35; 95% CI = 1.20-1.53), specifically for cannabis (OR = 1.26; 95% CI = 1.07-1.48) and opioid (OR = 1.56; 95% CI = 1.23-1.99) dependence. This is the first study to show that the proportion of psychiatric treatment is much elevated among subjects seeking treatment for cannabis dependence, and that a history of psychiatric problems is associated with higher rates of reentry into substance abuse treatment. SN - 0740-5472 UR - https://www.unboundmedicine.com/medline/citation/17306720/Psychopathology_among_cannabis_dependent_treatment_seekers_and_association_with_later_substance_abuse_treatment_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0740-5472(06)00218-2 DB - PRIME DP - Unbound Medicine ER -